FIRMQUARRY / COMPANY INTELLIGENCE
['URTICA Sp. z o.o.', 'ASCLEPIOS S.A.', 'BAXTER POLSKA Sp. z o.o.', 'SALUS INTERNATIONAL Sp. z o.o.', 'Delfarma Sp. z o.o.', 'Janssen-Cilag Polska Sp. z o.o.', 'NEUCA S.A.', 'Sanofi Sp. z o.o.', 'Takeda Pharma Sp. z o.o.', 'KOMTUR POLSKA SPÓŁKA Z O. O.', 'GSK SERVICES Sp. z o.o.', 'BAYER Sp. z o.o.']
Not reported · Verified headquarters unavailable
Track with Pro
Data last updated Oct 22, 2026 · Source: official procurement and company-intelligence sources
General information
- Legal name
- ['URTICA Sp. z o.o.', 'ASCLEPIOS S.A.', 'BAXTER POLSKA Sp. z o.o.', 'SALUS INTERNATIONAL Sp. z o.o.', 'Delfarma Sp. z o.o.', 'Janssen-Cilag Polska Sp. z o.o.', 'NEUCA S.A.', 'Sanofi Sp. z o.o.', 'Takeda Pharma Sp. z o.o.', 'KOMTUR POLSKA SPÓŁKA Z O. O.', 'GSK SERVICES Sp. z o.o.', 'BAYER Sp. z o.o.']
- First / latest observed
- Nov 3, 2026 — Nov 3, 2026
One source-backed chronology
Timeline
Business change, facilities, workforce, corporate events, and government activity appear chronologically.
- GovernmentAward announced
Dostawa produktów leczniczych w ramach programów lekowych, poza programami oraz chemioterapii w podziale na 42 Części
Disclosed procurement context
Government Business
Money leads this view. Values represent disclosed obligations and procurement amounts—not company revenue.
Global government business
Markets and currencies remain separate; incompatible currencies are never summed.
| Market | Disclosed value | Currency | Latest activity | Processes |
|---|---|---|---|---|
| POL | PLN 18M | PLN | Nov 3, 2026 | 1 |
Evidence and identifiers
Sources & Coverage
Technical identifiers live here, with retained official links and visible coverage limitations.
Source identifiers
- OCDS_PARTYeu_ted:52d8e62a-e8c4-425d-ba99-da4dab14e981:52e07780-3a77-402e-b76d-f7e50488bf3e:0 · source ↗